CLTEF   $12.08  -2.50% Market Open

Calliditas Therapeutics AB
Total Cash
totalCashPerShare
EBITDA
Total Debt
quickRatio
currentRatio
Total Revenue
debtToEquity
Revenue/Share
ROA
ROE
grossProfits 787.68M
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 405.22M
forwardPE
floatShares
sharesOutstanding 53.67M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.14%
heldPercentInstitutions 0.39%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon
trailingEps -1.07%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 47
lastUpdated May 29, 2023, 7:52 p.m.